Institut Català de la Salut
[Ornello R] Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy. [Caponnetto V] Department of Life, Health and Environmental Sciences, University of L’Aquila, L’Aquila, Italy. [Ahmed F] Hull University Teaching Hospitals NHS Trust, Hull, UK. [Al-Khazali HM] Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. [Ambrosini A] Headache Clinic - IRCCS NEUROMED, Pozzilli, Italy. [Ashina S] Department of Neurology and Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA. Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. [Pozo-Rosich P] Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-06-13T10:17:01Z
2025-06-13T10:17:01Z
2025-04
Acute treatment; Migraine treatment; Preventive treatment
Tractament agut; Tractament de la migranya; Tractament preventiu
Tratamiento agudo; Tratamiento de la migraña; Tratamiento preventivo
We here present evidence-based guidelines for the pharmacological treatment of migraine. These guidelines, created by the Italian Society for the Study of Headache and the International Headache Society, aim to offer clear, actionable recommendations to healthcare professionals. They incorporate evidence-based recommendations from randomized controlled trials and expert-based opinions. The guidelines follow the Grading of Recommendations, Assessment, Development and Evaluation approach for assessing the quality of evidence. The guideline development involved a systematic review of literature across multiple databases, adherence to Cochrane review methods, and a structured framework for data extraction and interpretation. Although the guidelines provide a robust foundation for migraine treatment, they also highlight gaps in current research, such as the paucity of head-to-head drug comparisons and the need for long-term outcome studies. These guidelines serve as a resource to standardize migraine treatment and promote high-quality care across different healthcare settings.
Article
Versió publicada
Anglès
Migranya - Tractament; Analgèsics - Ús terapèutic; DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Headache Disorders::Headache Disorders, Primary::Migraine Disorders; Other subheadings::Other subheadings::Other subheadings::/drug therapy; CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Peripheral Nervous System Agents::Sensory System Agents::Analgesics; Other subheadings::Other subheadings::/therapeutic use; ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::trastornos con cefaleas::cefaleas primarias::trastornos migrañosos; Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia; COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::fármacos del sistema nervioso periférico::fármacos del sistema sensitivo::analgésicos; Otros calificadores::Otros calificadores::/uso terapéutico
SAGE Publications
Cephalalgia;45(4)
https://doi.org/10.1177/03331024241305381
Attribution-NonCommercial 4.0 International
http://creativecommons.org/licenses/by-nc/4.0/
Articles científics - HVH [3396]
Articles científics - VHIR [1655]